{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:37:10Z","timestamp":1787161030449,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection Prevention in Practice"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.infpip.2021.100127","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T07:40:12Z","timestamp":1613461212000},"page":"100127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation"],"prefix":"10.1016","volume":"3","author":[{"given":"Omar","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy N.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaneet","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitu Karki","family":"Maskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.infpip.2021.100127_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.infpip.2021.100127_bib2","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1012413","article-title":"Host and pathogen factors for Clostridium difficile infection and colonization","volume":"365","author":"Loo","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.infpip.2021.100127_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.infpip.2021.100127_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jac\/dkr508","article-title":"Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics","volume":"67","author":"Hensgens","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.infpip.2021.100127_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/IPC.0000000000000350","article-title":"Diagnosis and treatment of Clostridium difficile infection (CDI)","volume":"24","author":"Gerding","year":"2016","journal-title":"Infect Dis Clin Pract (Baltim Md)"},{"issue":"5","key":"10.1016\/j.infpip.2021.100127_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.infpip.2021.100127_bib7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(83)91036-X","article-title":"Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis","volume":"2","author":"Teasley","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.infpip.2021.100127_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciu313","article-title":"Polymer alternative for CDI treatment (PACT) investigators. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials","volume":"59","author":"Johnson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.infpip.2021.100127_bib9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A\u00a0comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.infpip.2021.100127_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinids\/22.5.813","article-title":"Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea","volume":"22","author":"Wenisch","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.infpip.2021.100127_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0032-1329390","article-title":"Surgical management of Clostridium difficile colitis","volume":"25","author":"Seltman","year":"2012","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.infpip.2021.100127_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcgg.2015.06.003","article-title":"Evaluation of advanced age as a risk factor for severe Clostridium difficile infection","volume":"7","author":"Patel","year":"2016","journal-title":"J\u00a0Clin Gerontol Geriatr"},{"issue":"12","key":"10.1016\/j.infpip.2021.100127_bib13","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/cid\/cis786","article-title":"Clostridium difficile ribotype does not predict severe infection","volume":"55","author":"Walk","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.infpip.2021.100127_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/1471-2334-13-316","article-title":"Derivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection","volume":"13","author":"Butt","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.infpip.2021.100127_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098400","article-title":"Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review","volume":"9","author":"Abou Chakra","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.infpip.2021.100127_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bjid.2015.05.005","article-title":"Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico","volume":"19","author":"Hern\u00e1ndez-Garc\u00eda","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.infpip.2021.100127_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.infpip.2021.100127_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2334-13-148","article-title":"Derivation and validation of a simple clinical bedside\u00a0score (ATLAS) for Clostridium difficile infection, which predicts response to therapy","volume":"13","author":"Miller","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.infpip.2021.100127_bib19","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201810001-02742","article-title":"Charlson comorbidity index (CCI): an independent predictor of outcomes in Clostridium difficile infection (CDI): 2743","volume":"113","author":"Baiomi","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.infpip.2021.100127_bib20","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2008.02198.x","article-title":"Clinical review of the management of fulminant Clostridium difficile infection","volume":"103","author":"Jaber","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.infpip.2021.100127_bib21","first-page":"450","article-title":"Fulminant Clostridium difficile colitis","volume":"13","author":"Adams","year":"2007","journal-title":"Curr Opin Crit Care"}],"container-title":["Infection Prevention in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590088921000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590088921000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:31:26Z","timestamp":1762911086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590088921000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2590088921000159"],"URL":"https:\/\/doi.org\/10.1016\/j.infpip.2021.100127","relation":{},"ISSN":["2590-0889"],"issn-type":[{"value":"2590-0889","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory markers predictive of fulminant Clostridioides difficile infection refractory to fluid resuscitation","name":"articletitle","label":"Article Title"},{"value":"Infection Prevention in Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.infpip.2021.100127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}],"article-number":"100127"}}